UPS, which is the world’s leading provider of intricate healthcare logistics, on June 22, 2026, announced its $48 million investment in the 27 temperature-controlled freight cross-dock facilities throughout the world.
Strategically located in major U.S. and international markets such as Europe and Asia, as well as the Americas, these 27 temperature-controlled freight cross-dock facilities are engineered for speed as well as short-term storage between air along with ground movements – all with particular temperature requirements. The news bolsters the global cold-chain network of UPS as demand increases for medicines that require stringent temperatures of 2 to 8 degrees Celsius, 15 to 25 degrees Celsius, and frozen.
Growth Market Reports says that the industry consumption of temperature-sensitive biologics will increase at a CAGR of 8.3% through 2033 so as to reach a projected $39.1 billion. Meeting this requirement calls for cold chain expertise to deliver product safety and quality right from manufacturing to patient.
According to EVP and President of International Healthcare and Supply Chain Solutions at UPS, Kate Gutmann, “We have aligned our investments with our healthcare customers’ specialized needs. Our global cross-dock facilities strengthen our end-to-end cold-chain capabilities to ensure critical treatments are delivered safely and reliably to patients around the world. This effort – and all of our work in healthcare logistics – extends from a deep understanding that we’re doing more than moving packages. We are helping patients access the medications and treatments they need.”
One provider, full control: Integrated freight cross-docks minimize risk
- 27 temperature-controlled freight cross-docks allow for smooth movement across various transportation modes. All establishments are IATA CEIV Pharma certified, which is a worldwide industry standard when it comes to pharmaceutical handling and quality.
- An integrated single network means no handovers between providers, lowering risk and improving control.
- Enhanced responsibility along with real-time oversight safeguards high-value, temperature-sensitive therapies right from excursion and disruption.
- 24/7/365 control tower actively tracks shipments and detects risks as well as facilitates quick action so as to keep critical products flowing.
Demand for Precision Cold-Chain Solutions Expands Demand in Terms of Advanced Therapies Surging
The fast-expanding biologics pipeline is complicating cold-chain logistics. Approximately one-third of newly approved medications today are biologics, and more than 85% of them require temperature-controlled handling, states PharmaSource.
As therapies such as cell and gene and mRNA platforms as well as GLP-1 injectables enter the market, healthcare supply chains are growing more complicated and risk-sensitive. Temperature deviations are a big driver of that risk.
Cold-chain failure is projected to cost as much as $35 billion a year and contribute up to 50% of global vaccine waste, as reported by the WHO.
According to President of UPS Healthcare, John Bolla, “Biologics and personalized treatments are driving better, more targeted care for patients. These investments reflect our commitment to continue to align our leading end-to-end supply chain to protect innovative treatments and diagnostics, supporting better patient outcomes.”
Acquisition for Advantage – Investments to Scale Complex Healthcare Logistics
The cross-dock expansion of UPS is the latest step in its long-term investment when it comes to complex healthcare logistics, supported by acquisitions such as Bomi Group and Frigo Trans, as well as BPL in Europe, along with Andlauer Healthcare Group, located in North America.
Most recently, UPS has expanded its air hub in Korea’s Incheon so as to support fast-growing pharmaceutical trade shipments, as South Korea imported almost $9.7 billion worth of pharmaceutical products in 2025, says Observatory of Economic Complexity data.
This translates into a supply chain that is more responsive and which keeps high-value, time- as well as temperature-sensitive healthcare shipments traveling seamlessly through the air, ocean, and ground as well as the final mile. The integrated network of UPS is built for the complexity of modern business and is designed to expand with the demand of the future.
